Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/0b/8c/b5/0b8cb509-b600-5e80-60ed-e4dccfabe623/mza_6702031675298865395.jpg/600x600bb.jpg
Dishing The Science with Dr. Sue
Dr. Sue Pedersen
102 episodes
2 days ago
Some people don't tolerate GLP-1 medications, or need something more for weight loss. Could amylin agonists be the next hormone-based weight loss medications that could fill these gaps? Learn more: https://drsue.ca/2025/11/amylin-the-next-hormone-based-weight-management-medications/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patient...
Show more...
Medicine
Health & Fitness,
Nutrition
RSS
All content for Dishing The Science with Dr. Sue is the property of Dr. Sue Pedersen and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Some people don't tolerate GLP-1 medications, or need something more for weight loss. Could amylin agonists be the next hormone-based weight loss medications that could fill these gaps? Learn more: https://drsue.ca/2025/11/amylin-the-next-hormone-based-weight-management-medications/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patient...
Show more...
Medicine
Health & Fitness,
Nutrition
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/0b/8c/b5/0b8cb509-b600-5e80-60ed-e4dccfabe623/mza_6702031675298865395.jpg/600x600bb.jpg
OBESITY CANADA 2025 PHARMACOTHERAPY GUIDELINES: WHAT COULDN’T WE ANSWER?
Dishing The Science with Dr. Sue
4 minutes
2 months ago
OBESITY CANADA 2025 PHARMACOTHERAPY GUIDELINES: WHAT COULDN’T WE ANSWER?
In our NEW 2025 Obesity Canada Pharmacotherapy Clinical Practice Guidelines, we identified many existing gaps where data is lacking. Where did our Guidelines leave us wanting for more? Where is more research needed? Find out here! Learn more: https://drsue.ca/2025/08/obesity-canada-2025-pharmacotherapy-guidelines-what-couldnt-we-answer/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to gi...
Dishing The Science with Dr. Sue
Some people don't tolerate GLP-1 medications, or need something more for weight loss. Could amylin agonists be the next hormone-based weight loss medications that could fill these gaps? Learn more: https://drsue.ca/2025/11/amylin-the-next-hormone-based-weight-management-medications/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patient...